Sandoz, Amneal Get Mixed Ruling in State Drug Price-Fixing Case

Nov. 13, 2024, 5:26 PM UTC

Sandoz Inc., Pfizer Inc., and Amneal Pharmaceuticals Inc. are among a group of generic-drug manufacturers that will face some price-fixing claims brought by more than 40 states and US territories after a federal judge allowed them to move forward while dismissing others.

Judge Michael P. Shea of the US District Court for the District of Connecticut in a Tuesday order denied the pharma companies’ motion to dismiss monetary relief claims brought by states including California, Colorado, Connecticut, Florida, Michigan, and Mississippi.

The litigation is part of a larger push among states to collectively litigate antitrust cases against companies in ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.